Secondary Prevention

"Secondary Prevention" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The prevention of recurrences or exacerbations of a disease or complications of its therapy.

Descriptor ID	D055502
MeSH Number(s)	E02.897 N02.421.726.825 N06.850.780.750
Concept/Terms	Secondary Prevention Secondary Prevention Prevention, Secondary Preventions, Secondary Secondary Preventions Secondary Disease Prevention Disease Prevention, Secondary Disease Preventions, Secondary Prevention, Secondary Disease Preventions, Secondary Disease Secondary Disease Preventions Relapse Prevention Relapse Prevention Prevention, Relapse Preventions, Relapse Relapse Preventions Early Therapy Early Therapy Early Therapies Therapies, Early Therapy, Early

Below are MeSH descriptors whose meaning is more general than "Secondary Prevention".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Secondary Prevention [E02.897]
Health Care [N]
Health Care Facilities, Manpower, and Services [N02]
Health Services [N02.421]
Preventive Health Services [N02.421.726]
Secondary Prevention [N02.421.726.825]
Environment and Public Health [N06]
Public Health [N06.850]
Public Health Practice [N06.850.780]
Secondary Prevention [N06.850.780.750]

Below are MeSH descriptors whose meaning is related to "Secondary Prevention".

Below are MeSH descriptors whose meaning is more specific than "Secondary Prevention".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Secondary Prevention" by people in this website by year, and whether "Secondary Prevention" was a major or minor topic of these publications.

Bar chart showing 123 publications over 25 distinct years, with a maximum of 12 publications in 2011 and 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	2	2
2000	0	3	3
2001	0	4	4
2002	0	1	1
2003	0	4	4
2004	0	2	2
2005	0	5	5
2006	0	6	6
2007	0	7	7
2008	0	5	5
2009	0	3	3
2010	0	5	5
2011	1	11	12
2012	0	4	4
2013	3	8	11
2014	4	8	12
2015	3	1	4
2016	3	0	3
2017	0	4	4
2018	1	4	5
2019	1	1	2
2020	4	3	7
2021	4	3	7
2022	0	3	3
2024	1	1	2

Below are the most recent publications written about "Secondary Prevention" by people in Profiles.

Bao A, Karalis DG. Statin Therapy for Primary and Secondary Prevention in Older Adults. Curr Atheroscler Rep. 2024 Nov 25; 27(1):11.

View in: PubMed
Gibson CM, Duffy D, Korjian S, Bahit MC, Chi G, Alexander JH, Lincoff AM, Heise M, Tricoci P, Deckelbaum LI, Mears SJ, Nicolau JC, Lopes RD, Merkely B, Lewis BS, Cornel JH, Trebacz J, Parkhomenko A, Libby P, Sacks FM, Povsic TJ, Bonaca M, Goodman SG, Bhatt DL, Tendera M, Steg PG, Ridker PM, Aylward P, Kastelein JJP, Bode C, Mahaffey KW, Nicholls SJ, Pocock SJ, Mehran R, Harrington RA. Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction. N Engl J Med. 2024 May 02; 390(17):1560-1571.

View in: PubMed
Diaz-Arocutipa C, Saucedo-Chinchay J, Mamas MA, Vicent L. Influenza vaccine improves cardiovascular outcomes in patients with coronary artery disease: A systematic review and meta-analysis. Travel Med Infect Dis. 2022 May-Jun; 47:102311.

View in: PubMed
Chang RS, Leung WC, Vassallo M, Sykes L, Battersby Wood E, Kwan J. Antiepileptic drugs for the primary and secondary prevention of seizures after stroke. Cochrane Database Syst Rev. 2022 02 07; 2:CD005398.

View in: PubMed
Tai WA. Stroke: Long-Term Poststroke Management. FP Essent. 2022 Jan; 512:31-40.

View in: PubMed
Rhoades R, Tzeng D, Ruggiero N. Secondary stroke prevention in patients with patent foramen ovale. Curr Opin Hematol. 2021 09 01; 28(5):292-300.

View in: PubMed
Medranda GA, Zhang C, Doros G, Yerasi C, Case BC, Weintraub WS, Waksman R. Meta-Analysis of Usefulness of Antiplatelet Therapy in Ischemic Stroke or Transient Ischemic Attack. Am J Cardiol. 2021 08 15; 153:129-134.

View in: PubMed
Albers GW, Bernstein R, Brachmann J, Camm AJ, Fromm P, Goto S, Granger CB, Hohnloser SH, Hylek E, Krieger D, Passman R, Pines JM, Kowey P. Reexamination of the Embolic Stroke of Undetermined Source Concept. Stroke. 2021 08; 52(8):2715-2722.

View in: PubMed
McFadden JP, Cunningham LS, Ferguson FJ, Tziotzios C, McGrath JA. Synergistic multiple early therapy (SMET) for inflammatory diseases with pathogenic autoinflammatory feedback circuits. Br J Dermatol. 2021 08; 185(2):469-470.

View in: PubMed
Meyerhardt JA, Shi Q, Fuchs CS, Meyer J, Niedzwiecki D, Zemla T, Kumthekar P, Guthrie KA, Couture F, Kuebler P, Bendell JC, Kumar P, Lewis D, Tan B, Bertagnolli M, Grothey A, Hochster HS, Goldberg RM, Venook A, Blanke C, O'Reilly EM, Shields AF. Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial. JAMA. 2021 04 06; 325(13):1277-1286.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement